Pitavastatin Enhanced BMP-2 and Osteocalcin Expression by Inhibition of Rho-Associated Kinase in Human Osteoblasts
- 21 September 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 287 (2) , 337-342
- https://doi.org/10.1006/bbrc.2001.5597
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Anabolic Therapy for OsteoporosisJournal of Clinical Endocrinology & Metabolism, 2001
- The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.Nature Medicine, 2000
- Therapeutic Approaches to Bone DiseasesScience, 2000
- HMG-CoA Reductase Inhibitors and the Risk of FracturesJAMA, 2000
- HMG-CoA Reductase Inhibitors and the Risk of Hip Fractures in Elderly PatientsJAMA, 2000
- Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older womenThe Lancet, 2000
- Stimulation of Bone Formation in Vitro and in Rodents by StatinsScience, 1999
- What Can We Learn from Bone Biology for the Treatment for Osteoporosis?Osteoporosis International, 1999
- Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide SynthaseJournal of Biological Chemistry, 1997
- Bone Morphogenetic Protein-2Clinical Orthopaedics and Related Research, 1996